while litigation challenging the drug’s approval plays out in a lower court. The Alliance for Hippocratic Medicine, a coalition of anti-abortion groups, filed the complaint last year in Texas, arguing the Food and Drug Administration used an improper process when it approved mifepristone in 2000 and did not adequately review its safety in minors.
Ellen did the research when her OBGYN offered her the more widely prescribed misoprostol-only regimen. Afound 83 percent of patients who took both drugs had successfully expelled all the contents of their uterus, avoiding the need for follow-up care. That number dropped to 67 percent for patients who took a single dose of misoprostol.
While the risks of complications are low for either drug regimen, Dr. Bhavik Kumar, medical director for primary and transgender care at Planned Parenthood Gulf Coast in Houston, worries that side effects may cause more alarm in a “hostile landscape for pregnant people scrambling to access care.”encountered treatment delays at hospitals because of confusion surrounding the state’s strict abortion laws.
“It may take calling the pharmacist and having a conversation about this, and sometimes even escalating to managers to get the care for your patient,” the doctor said. “As physicians and providers, we’re absolutely willing to do that for patients. But the more patients that you need to do that for, the more time it takes. And the more time it takes from seeing other patients.”
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Reuters - 🏆 2. / 97 Read more »
Source: fox5ny - 🏆 587. / 51 Read more »